Cargando…

Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study

INTRODUCTION: Previous studies suggested that β-cell function markers such as fasting and postprandial serum C-peptide and C-peptide increment (FCPR, PCPR, and ΔCPR, respectively) may be useful in estimating glycemic response to glucagon-like peptide-1 receptor agonists. However, it remains elusive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshiji, Satoshi, Hasebe, Masashi, Iwasaki, Yorihiro, Shibue, Kimitaka, Keidai, Yamato, Seno, Yohei, Iwasaki, Kanako, Honjo, Sachiko, Fujikawa, Jun, Hamasaki, Akihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991285/ https://www.ncbi.nlm.nih.gov/pubmed/35285007 http://dx.doi.org/10.1007/s13300-022-01231-1

Ejemplares similares

Plant sterol hyperabsorption caused by uncontrolled diabetes in a patient with a heterozygous ABCG5 variant
por: Hasebe, Masashi, et al.
Publicado: (2022)

Exploratory study on glycemic control improvement for patients with diabetes mellitus by appropriate re-education on insulin self-injection technique during COVID-19 pandemic
por: Honjo, Sachiko, et al.
Publicado: (2023)

Sporadic Pseudohypoparathyroidism Type 1B in Monozygotic Twins: Insights Into the Pathogenesis of Methylation Defects
por: Keidai, Yamato, et al.
Publicado: (2021)

Sporadic Pseudohypoparathyroidism 1B in Monozygotic Twins: Insights Into the Pathogenesis of Methylation Defects
por: Keidai, Yamato, et al.
Publicado: (2021)

“Switched” metabolic acidosis in mitochondrial diabetes mellitus
por: Keidai, Yamato, et al.
Publicado: (2019)

Facilitating screening of Klinefelter syndrome among patients with diabetes
por: Seno, Yohei, et al.
Publicado: (2019)

A Case of Lymphocytic Infundibulo-neurohypophysitis Exhibiting Spontaneous Regression
por: Hasebe, Masashi, et al.
Publicado: (2023)

First Japanese Family With PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications
por: Yoshiji, Satoshi, et al.
Publicado: (2021)

Alu-Mediated MEN1 Gene Deletion and Loss of Heterozygosity in a Patient with Multiple Endocrine Neoplasia Type 1
por: Yoshiji, Satoshi, et al.
Publicado: (2020)

Successful Treatment of Postprandial Hyperinsulinemic Hypoglycemia After Billroth-II Gastrojejunostomy Using Octreotide
por: Hasebe, Masashi, et al.
Publicado: (2023)

Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials
por: Hasebe, Masashi, et al.
Publicado: (2023)

Correction: Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials
por: Hasebe, Masashi, et al.
Publicado: (2023)

Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma
por: Tsukaguchi, Ryo, et al.
Publicado: (2023)

Enlarged adrenal glands: the long-term consequence of Cushing’s disease
por: Iwasaki, Yorihiro, et al.
Publicado: (2019)

Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline
por: Shibue, Kimitaka, et al.
Publicado: (2022)

Distribution and hormonal characterization of primary murine L cells throughout the gastrointestinal tract
por: Suzuki, Kazuyo, et al.
Publicado: (2017)

Dulaglutide‐combined basal plus correction insulin therapy contributes to ideal glycemic control in non‐critical hospitalized patients
por: Fushimi, Nobutoshi, et al.
Publicado: (2019)

Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion
por: Joo, Erina, et al.
Publicado: (2015)

The effect of Dulaglutide on glycemic and weight control in patients with type 2 diabetes
por: Ruda, Alexandru Ioan, et al.
Publicado: (2023)

Chronic primary adrenal insufficiency after unilateral adrenonephrectomy: A case report
por: Yoshiji, Satoshi, et al.
Publicado: (2017)

The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes
por: Wada, Yoshiharu, et al.
Publicado: (2013)

Necrotizing Pancreatitis Secondary to Dulaglutide Use
por: Bhat, Salman Zahoor, et al.
Publicado: (2021)

FRI638 Glycemic And Cost Outcomes In Hispanic/Latino People With Type 2 Diabetes Initiating Dulaglutide Or Basal Insulin In The US
por: Hoog, Meredith, et al.
Publicado: (2023)

Reversal of Cushing Pigmentation by Sunitinib
por: Iwasaki, Yorihiro, et al.
Publicado: (2019)

An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report
por: Saito, Wataru, et al.
Publicado: (2023)

Mode of administration of dulaglutide: implications for treatment adherence
por: Amblee, Ambika
Publicado: (2016)

Dulaglutide Alleviates LPS-Induced Injury in Cardiomyocytes
por: Wang, Rijun, et al.
Publicado: (2021)

Exacerbation of atrial fibrillation related to dulaglutide use
por: Lee, Jayden, et al.
Publicado: (2021)

A Case of Dulaglutide-Induced Vaginal Bleed
por: Vaccaro, Christopher J, et al.
Publicado: (2023)

Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China
por: Ruan, Zhen, et al.
Publicado: (2022)

Rapid exacerbation of lymphocytic infundibuloneurohypophysitis
por: Shibue, Kimitaka, et al.
Publicado: (2017)

Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin
por: Uchinuma, Hiroyuki, et al.
Publicado: (2020)

Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19
por: Matsuyama, Toshifumi, et al.
Publicado: (2021)

Advances in the treatment of type 2 diabetes: impact of dulaglutide
por: Thompson, Angela M, et al.
Publicado: (2016)

An Uncommon Case of Dulaglutide-Related Morbilliform Drug Eruption
por: Kyriakos, Georgios, et al.
Publicado: (2022)

Correction to Dulaglutide Alleviates LPS-Induced Injury in Cardiomyocytes
por: Wang, Rijun, et al.
Publicado: (2022)

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
por: Konig, Manige, et al.
Publicado: (2021)

Association between eating behavior and poor glycemic control in Japanese adults
por: Iwasaki, Takahiro, et al.
Publicado: (2019)

Efficacy of Dulaglutide in Chinese Patients with Type 2 Diabetes and Different Glycemic Patterns: a Post-hoc Analysis of the Phase 3 AWARD-CHN2 Trial
por: Li, Qifu, et al.
Publicado: (2021)

Dulaglutide (Trulicity)-Induced Acute Pancreatitis: A Case Report
por: Khan, Abu baker, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ht6rapjsckjuvvjfvtlifat5e1